News Digest / StockInvest.us

Author: StockInvest.us

06:07pm, Tuesday, May 06, 2025
BioAtla, Inc. (NASDAQ: BCAB) - Company Overview BioAtla, Inc. is a clinical-stage biopharmaceutical company focusing on developing conditionally active biologics (CABs) for cancer treatment. The company's innovative platform aims to create highly selective therapies that target tumor-specific ant...